Detalhe da pesquisa
1.
Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
Mod Pathol
; 37(3): 100424, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38219954
2.
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-up From a Phase 3 Trial.
J Urol
; : 101097JU0000000000004020, 2024 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38704840
3.
Comprehensive Genomic Profiling of NF2-Mutated Kidney Tumors Reveals Potential Targets for Therapy.
Oncologist
; 28(7): e508-e519, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36917021
4.
Comparative Genomic Landscape of Urothelial Carcinoma of the Bladder Among Patients of East and South Asian Genomic Ancestry.
Oncologist
; 28(10): e910-e920, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37196060
5.
Artificial Intelligence-Based PTEN Loss Assessment as an Early Predictor of Prostate Cancer Metastasis After Surgery: A Multicenter Retrospective Study.
Mod Pathol
; 36(10): 100241, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37343766
6.
Adjuvant therapy for renal cell carcinoma in 2023: hopes and disappointments.
World J Urol
; 41(7): 1855-1859, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37310435
7.
Does a prior cancer diagnosis impact PSA testing? Results from the National Health Interview Survey.
Can J Urol
; 30(3): 11551-11557, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344467
8.
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study.
Oncologist
; 27(12): 1016-1024, 2022 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35881043
9.
The association of sexual orientation with prostate, breast, and cervical cancer screening and diagnosis.
Cancer Causes Control
; 33(12): 1421-1430, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36085431
10.
Financial Toxicity and Its Association With Prostate and Colon Cancer Screening.
J Natl Compr Canc Netw
; 20(9): 981-988, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075394
11.
Asymmetric Hsp90 N domain SUMOylation recruits Aha1 and ATP-competitive inhibitors.
Mol Cell
; 53(2): 317-29, 2014 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24462205
12.
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.
Lancet Oncol
; 22(1): 107-117, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33253641
13.
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
Cancer
; 127(24): 4557-4564, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379803
14.
Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Cancer
; 127(21): 3957-3966, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34343338
15.
Tumor suppressor Tsc1 is a new Hsp90 co-chaperone that facilitates folding of kinase and non-kinase clients.
EMBO J
; 36(24): 3650-3665, 2017 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29127155
16.
Reoperative Partial Nephrectomy-Does Previous Surgical Footprint Impact Outcomes?
J Urol
; 206(3): 539-547, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33904762
17.
Surgical Insights for the Management of Variant Histology in Renal Cell Carcinoma.
Int Braz J Urol
; 47(5): 935-942, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650834
18.
Chemical Perturbation of Oncogenic Protein Folding: from the Prediction of Locally Unstable Structures to the Design of Disruptors of Hsp90-Client Interactions.
Chemistry
; 26(43): 9459-9465, 2020 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32167602
19.
Liquid buccal mucosa graft endoscopic urethroplasty: a validation animal study.
World J Urol
; 38(9): 2139-2145, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175459
20.
Genomic Features for Therapeutic Insights of Chemotherapy-Resistant, Primary Mediastinal Nonseminomatous Germ Cell Tumors and Comparison with Gonadal Counterpart.
Oncologist
; 24(4): e142-e145, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30659078